首页> 外文OA文献 >Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond

【2h】

Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond

机译：HER2 +乳腺癌免疫治疗的临床开发：对HER2针对单克隆抗体及超越的综述

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Ricardo L. B. Costa; Brian J. Czerniecki;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical development of immunotherapies for HER2 + breast cancer: a review of HER2-directed monoclonal antibodies and beyond [J] . Ricardo L. B. Costa, Brian J. Czerniecki NPJ breast cancer. . 2020,第1期

机译：HER2 +乳腺癌免疫治疗的临床开发：对HER2针对单克隆抗体及超越的综述
2. An Approach to Breast Cancer Immunotherapy: The Apoptotic Activity of Recombinant Anti-Interleukin-6 Monoclonal Antibodies in Intact Tumour Microenvironment of Breast Carcinoma [J] . Abou-Shousha S., Moaaz M., Sheta M., Scandinavian journal of immunology. . 2016,第6期

机译：乳腺癌免疫治疗的一种方法：重组抗白介素6单克隆抗体在乳腺癌完整肿瘤微环境中的凋亡活性。
3. Clinical and pharmacological characteristics of trastuzumab emtansine, an antibody-drug conjugate in the treatment of HER2+ breast cancer [J] . Vincent Launay-Vacher, Eric-Charles Antoine Journal de pharmacie clinique =: International journal of clinical pharmacy . 2012,第4期

机译：曲妥珠单抗Emtansine（一种抗体药物结合物）在治疗HER2 +乳腺癌中的临床和药理学特征
4. Pre-Clinical Development of CXCR4 Antagonist Antibody for Cancer Immunotherapy [C] . Dmitry Poteryaev, Alexer Piskunov, Maria Aksenova, International Molecular Medicine Tri-Conference. . 2016

机译：CXCR4拮抗剂抗体癌症免疫疗法的临床开发
5. Determination of the potential use of beta-glucan as an adjuvant for monoclonal antibody immunotherapy of cancer. [D] . Hong, Feng. 2002

机译：确定β-葡聚糖作为癌症单克隆抗体免疫疗法佐剂的潜在用途。
6. Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond [O] . Ricardo L. B. Costa, Brian J. Czerniecki 2020

机译：HER2 +乳腺癌免疫疗法的临床发展：HER2指导的单克隆抗体及其他研究综述
7. An Approach to Breast Cancer Immunotherapy: The Apoptotic Activity of Recombinant Anti-Interleukin-6 Monoclonal Antibodies in Intact Tumour Microenvironment of Breast Carcinoma [O] . S. Abou-Shousha, M. Moaaz, M. Sheta, 2016

机译：乳腺癌免疫治疗方法：重组抗白细胞介素-6单克隆抗体在乳腺癌的完整肿瘤微环境中的凋亡活性
8. Does Combination Immunotherapy with Human Monoclonal Antibodies Against HER2 and CXCR4 Augment Breast Cancer Killing in Vitro and in Vivo [R] . Marasco, W. A. 2007

机译：与HER2和CXCR4的人单克隆抗体联合免疫治疗是否会增加乳腺癌的体外和体内杀伤力

Clinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond

著录项

引文网络

相似文献

相关主题

期刊订阅